Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.0000 |
Ask | 1.5000 |
Strike | 582.50 |
Expiry date | 2024-06-21 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.